Cargando…
Pharmacological Inhibition of STAT6 Ameliorates Myeloid Fibroblast Activation and Alternative Macrophage Polarization in Renal Fibrosis
A hallmark of chronic kidney disease is renal fibrosis, which can result in progressive loss of kidney function. Currently, there is no effective therapy for renal fibrosis. Therefore, there is an urgent need to identify potential drug targets for renal fibrosis. In this study, we examined the effec...
Autores principales: | Jiao, Baihai, An, Changlong, Tran, Melanie, Du, Hao, Wang, Penghua, Zhou, Dong, Wang, Yanlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426438/ https://www.ncbi.nlm.nih.gov/pubmed/34512669 http://dx.doi.org/10.3389/fimmu.2021.735014 |
Ejemplares similares
-
STAT6 Deficiency Attenuates Myeloid Fibroblast Activation and Macrophage Polarization in Experimental Folic Acid Nephropathy
por: Jiao, Baihai, et al.
Publicado: (2021) -
Pharmacological Inhibition of S100A4 Attenuates Fibroblast Activation and Renal Fibrosis
por: Wen, Jia, et al.
Publicado: (2022) -
Disruption of CXCR6 Ameliorates Kidney Inflammation and Fibrosis in Deoxycorticosterone Acetate/Salt Hypertension
por: Wu, Yuanbo, et al.
Publicado: (2020) -
Pharmacological Inhibition of STING/TBK1 Signaling Attenuates Myeloid Fibroblast Activation and Macrophage to Myofibroblast Transition in Renal Fibrosis
por: Zeng, Haimei, et al.
Publicado: (2022) -
Pharmacologic inhibition of STAT5 in acute myeloid leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2018)